This document is page 64 of a Cowen Collaborative Insights market research report dated February 25, 2019. It analyzes the healthcare payor and provider perspectives on CBD oils and medical marijuana, specifically discussing reimbursement challenges with CMS and commercial insurers, as well as policy shifts at Intermountain Healthcare in Utah. The document bears a 'HOUSE_OVERSIGHT_024880' Bates stamp, indicating it was part of a document production for a House Oversight Committee investigation.
Discussion 0
No comments yet
Be the first to share your thoughts on this epstein entity